Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10918-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10918-1-AP, RRID:AB_2075288
- Product name
- CDC27; APC3 antibody
- Antibody type
- Polyclonal
- Description
- CDC27; APC3 antibody (Cat. #10918-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: FC, IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references PSMD14 promotes breast cancer progression by reducing K63-linked ubiquitination on FOXM1 and activating the PI3K/AKT/mTOR pathway.
Inhibition of CDC27 O-GlcNAcylation coordinates the antitumor efficacy in multiple myeloma through the autophagy-lysosome pathway.
F-box protein FBXO32 ubiquitinates and stabilizes D-type cyclins to drive cancer progression.
ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability.
APC/C-regulated CPT1C promotes tumor progression by upregulating the energy supply and accelerating the G1/S transition.
The ubiquitin E3 ligase APC/C(Cdc20) mediates mitotic degradation of OGT.
CDC27-ODC1 Axis Promotes Metastasis, Accelerates Ferroptosis and Predicts Poor Prognosis in Neuroblastoma.
EGFR-ERK induced activation of GRHL1 promotes cell cycle progression by up-regulating cell cycle related genes in lung cancer.
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
Liu Y, Wen S, Wang W, Liu Q, Su L, Zhang Y, Bai C, Pu S, Zhang Q, Wang J
International journal of biological macromolecules 2025 Oct;327(Pt 1):147275
International journal of biological macromolecules 2025 Oct;327(Pt 1):147275
Inhibition of CDC27 O-GlcNAcylation coordinates the antitumor efficacy in multiple myeloma through the autophagy-lysosome pathway.
Wu HQ, Qin RC, Li WJ, Liu JN, Deng C, Zheng ZH, Zheng JP, Liu Y, Meng YF, Tang C, Tan HM, Duan FF, Tang Y, Xiao F, Lu LW, Dai XY, Ma KY
Acta pharmacologica Sinica 2025 Jul;46(7):2041-2055
Acta pharmacologica Sinica 2025 Jul;46(7):2041-2055
F-box protein FBXO32 ubiquitinates and stabilizes D-type cyclins to drive cancer progression.
Li F, Yu H, Zhang Y, Ma Y, Chen X, Zhang J, Sun L, Guo R, Wu Y, Zheng P, Wang X, Bie P, He F, Zhang L, Xie C, Xiong H
Nature communications 2025 Apr 30;16(1):4060
Nature communications 2025 Apr 30;16(1):4060
ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability.
Dong Q, Wang D, Song C, Gong C, Liu Y, Zhou X, Yue J, Hu Y, Liu H, Zhu L, Niu X, Zheng T, Zhang X, Jin J, Wang T, Ju R, Wang C, Jiang Q, Gao T, Jin Y, Li P, Wang Y, Zhang C, Wang GF, Cao C, Liu X
Cell death and differentiation 2024 Oct;31(10):1285-1301
Cell death and differentiation 2024 Oct;31(10):1285-1301
APC/C-regulated CPT1C promotes tumor progression by upregulating the energy supply and accelerating the G1/S transition.
Zhao H, Cheng X, Yan L, Mi F, Wang W, Hu Y, Liu X, Fan Y, Min Q, Wang Y, Zhang W, Wu Q, Zhan Q
Cell communication and signaling : CCS 2024 May 23;22(1):283
Cell communication and signaling : CCS 2024 May 23;22(1):283
The ubiquitin E3 ligase APC/C(Cdc20) mediates mitotic degradation of OGT.
Meng L, Dong R, Mi W, Qin K, Ouyang K, Sun J, Li J
The Journal of biological chemistry 2024 Jul;300(7):107448
The Journal of biological chemistry 2024 Jul;300(7):107448
CDC27-ODC1 Axis Promotes Metastasis, Accelerates Ferroptosis and Predicts Poor Prognosis in Neuroblastoma.
Qiu L, Zhou R, Luo Z, Wu J, Jiang H
Frontiers in oncology 2022;12:774458
Frontiers in oncology 2022;12:774458
EGFR-ERK induced activation of GRHL1 promotes cell cycle progression by up-regulating cell cycle related genes in lung cancer.
He Y, Gan M, Wang Y, Huang T, Wang J, Han T, Yu B
Cell death & disease 2021 Apr 30;12(5):430
Cell death & disease 2021 Apr 30;12(5):430
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
Feng Z, Zhang L, Zhou J, Zhou S, Li L, Guo X, Feng G, Ma Z, Huang W, Huang F
Oncotarget 2017 Jan 24;8(4):6304-6318
Oncotarget 2017 Jan 24;8(4):6304-6318
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- K-562 cells were subjected to SDS PAGE followed by western blot with 10918-1-AP(CDC27; APC3 antibody) at dilution of 1:600
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunofluorescent analysis of SH-SY5Y cells, using CDC27 antibody 10918-1-AP at 1:50 dilution and FITC-labeled donkey anti-rabbit IgG(green). Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- IP Result of anti-CDC27; APC3 (IP:10918-1-AP, 3ug; Detection:10918-1-AP 1:600) with K-562 cells lysate 11000ug.
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunohistochemical of paraffin-embedded human prostate cancer using 10918-1-AP(CDC27; APC3 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue